Transdigm Group INC Form 4 insider transactions

NYSE
TransDigm Group's CEO, Kevin Stein, exercised stock options and sold shares held indirectly through the Fortuna Trust on April 12, 2024.
NYSE
Joel Reiss, Co-Chief Operating Officer of TransDigm Group INC, exercised stock options and sold shares on April 15, 2024, according to a Form 4 filing with the SEC.
NYSE
Director Jorge Valladares acquired 31 shares of TransDigm Group INC common stock on March 22, 2024, in lieu of a semi-annual director fee.
NYSE
Director Robert J. Small reports acquiring shares in lieu of director fees and indirect ownership through various entities, while also disposing of shares.
NYSE
Director Michele Santana acquired 31 shares of TransDigm Group INC common stock on March 22, 2024, in lieu of a semi-annual director fee.
NYSE
Director Sean P. Hennessy acquired 31 shares of TransDigm Group INC common stock on March 22, 2024, in lieu of a semi-annual director fee.
NYSE
Director Jane M. Cronin acquired 31 shares of TransDigm Group INC common stock in lieu of a semi-annual director fee on March 22, 2024.
NYSE
Director David Barr acquired 31 shares of TransDigm Group INC common stock on March 22, 2024, in lieu of a semi-annual director fee.
NYSE
Director Michael Graff increased his holdings in TransDigm Group INC through the receipt of stock in lieu of director fees and transactions involving trusts and his spouse.
NYSE
Joel Reiss, Co-Chief Operating Officer of TransDigm Group Inc., exercised stock options and sold shares on March 15, 2024, according to a Form 4 filing with the SEC.
NYSE
Director Michael Graff reports the disposal of TransDigm Group shares held indirectly through trusts, with transactions occurring on March 14, 2024.
NYSE
Director Jorge Valladares exercised stock options and sold shares of TransDigm Group INC on March 12, 2024.
NYSE
Kevin Stein, President & CEO of TransDigm Group INC, exercised stock options and sold shares held indirectly through the Fortuna Trust on March 12, 2024.
NYSE
Director Jorge Valladares exercised stock options and sold shares of TransDigm Group INC on March 8, 2024.
NYSE
Director Robert Small reports selling TransDigm Group INC shares on February 27, 2024.
NYSE
Director Jorge Valladares exercised stock options and sold shares of TransDigm Group INC on February 26, 2024, according to a Form 4 filing with the SEC.
NYSE
Director Jorge Valladares exercised stock options and sold shares of TransDigm Group INC on February 26, 2024, according to a Form 4 filing with the SEC.
NYSE
Michael Lisman, Co-Chief Operating Officer of TransDigm Group INC, exercised stock options and sold shares of common stock on February 23 and 26, 2024.